1. Benchmarking leading countries' accreditation programs for ambulatory healthcare organizations. |
Page:1132—1143 |
2. Pharmacologic treatment of osteoarthritis. |
Page:1123—1131 |
3. The diagnosis and treatment of lymphedema. |
Page:1115—1122 |
4. Diagnosis and treatment of dementia in primary care. |
Page:1104—1112 |
5. Antivenom for snake bite in Korea. |
Page:1091—1103 |
6. Antidote for acquired methemoglobinemia: methylene blue. |
Page:1084—1090 |
7. Antidotes of cyanide intoxication. |
Page:1076—1083 |
8. Antidote for acetaminophen poisoning: N-acetylcysteine. |
Page:1067—1075 |
9. Antidote for organophosphate insecticide poisoning: atropine and pralidoxime. |
Page:1057—1066 |
10. Need for stocking of emergency antidotes. |
Page:1054—1056 |
11. The limitation of the current accreditation system for basic medical education in Republic of Korea. |
Page:1050—1052 |
12. An overview and considerations in prescribing H1-antihistamine. |
Page:231—239 |
13. Prevention and management of the diabetic foot. |
Page:220—228 |
14. Role of physician in reducing health inequity. |
Page:213—219 |
15. Current status of policy developments in tackling health inequalities and the next steps to be taken in Korea. |
Page:206—212 |
16. Global trends in health equity policy: lessons from experiences in the UK, the Netherlands, Sweden, and the World Health Organization. |
Page:195—205 |
17. Equity in health care: current situation in South Korea. |
Page:184—194 |
18. Socioeconomic inequalities in health risk factors in Korea. |
Page:175—183 |
19. Socioeconomic inequalities in health status in Korea. |
Page:167—174 |
20. One wing of nation's health: reducing health inequalities. |
Page:165—166 |
21. Can a medical regulatory system be implemented in Korea?. |
Page:158—163 |
22. Current status of healthcare and effective health aid strategies in North Korea. |
Page:368—374 |
23. Overview of healthcare system in North Korea. |
Page:358—367 |
24. The North Korean health and healthcare: issues and strategies. |
Page:356—357 |
25. The end of internship training in South Korea. |
Page:352—354 |
26. Inhalation medications in chronic airway disease. |
Page:625—631 |
27. Changing concepts of cancer stem cells and their application into targeted therapy for cancer. |
Page:611—624 |
28. Cardiopulmonary resuscitation update. |
Page:600—608 |
29. Anemia and nutrition in end stage renal disease patient. |
Page:592—599 |
30. The efficacy of dialysis adequacy. |
Page:583—591 |
31. Cardiovascular disease in end-stage renal disease. |
Page:576—582 |
32. Clinical outcomes by dialysis modality in patients with end stage renal disease. |
Page:569—575 |
33. Current status of dialysis therapy for ESRD patients in Korea. |
Page:562—568 |
34. Current status and future in patients with end stage renal disease in Korea. |
Page:560—561 |
35. The role of physicians in preventing school bullying. |
Page:554—558 |
36. Economic burden of otitis media and a survey of physicians for its practice and claim codes in Korea. |
Page:62—71 |
37. New oral anticoagulants. |
Page:57—61 |
38. Hair characteristics and androgenetic alopecia in Koreans. |
Page:45—54 |
39. Constraint-induced movement therapy. |
Page:38—44 |
40. Noninvasive brain stimulation: repetitive transcranial magnetic stimulation and transcranial direct current stimulation. |
Page:30—37 |
41. Robotics in rehabilitation for patients with brain disease. |
Page:23—29 |
42. Virtual reality based stroke rehabilitation. |
Page:16—22 |
43. Treatment of dysphagia in patients with brain disorders. |
Page:7—15 |
44. Current update of therapeutic interventions for stroke rehabilitation. |
Page:5—6 |
45. A new year's greeting message. |
Page:2—3 |
46. Biologic response modifiers. |
Page:135—141 |
47. Does our society have the proper understanding of death?. |
Page:129—134 |
48. Diagnosis and management of muscle pain. |
Page:120—126 |
49. National Evidence-based Collaborating Agency (NECA) Round-table Conference Consensus Statement: multidisciplinary responses to suicide, the first ranked cause of death in adolescents. |
Page:111—119 |
50. Current interventions, strategies, and networking of adolescent suicide. |
Page:100—110 |
51. Recent statistics and risk factors of suicide in children and adolescents. |
Page:93—99 |
52. Adolescent suicide in Korean society. |
Page:91—92 |
53. The establishment of medical terms in Korea. |
Page:86—89 |
54. Estimation of the prevalence of Korean adults aged 50 years or more with knee osteoarthritis based on the data from fifth Korea National Health and Nutrition Examination Survey. |
Page:431—436 |
55. Pharmacologic management of cardiac arrhythmias. |
Page:425—430 |
56. Sleep disorders medicine. |
Page:410—422 |
57. Recent advances in thrombolysis of acute ischemic stroke. |
Page:402—409 |
58. Plan on establishment of post-unification North Korean medical safety net. |
Page:394—401 |
59. The experiences of system integration countries informing the potential unification of the Korean peninsula's healthcare system. |
Page:389—393 |
60. The integration process of North Korean defector physicians into the South Korean medical system. |
Page:383—388 |
61. Current status and prospects of exchange of health officials from South and North Korea through non-governmental organizations. |
Page:375—382 |
62. Plasma volume expanders: classification and characteristics of colloids. |
Page:924—932 |
63. Nonoperative management of ankle arthritis. |
Page:917—923 |
64. Surgical treatments of the ankle arthritis. |
Page:908—914 |
65. Primary care research in South Korea: its importance and enhancing strategies for enhancement. |
Page:899—907 |
66. Reforming medical education for strengthening primary care. |
Page:891—898 |
67. Payment reform for the improvement of primary care in Korea. |
Page:881—890 |
68. Standard model and quality appraisal framework for the organization of primary care. |
Page:866—880 |
69. Concept, values, current status and prospect of primary care in Korea. |
Page:856—865 |
70. Strategies to strengthen primary care for the efficiency and equity of health care in Korea. |
Page:853—855 |
71. The hope and hype of stem cell therapy. |
Page:848—851 |
72. Necessity and the strategy to establish a national poison center in Korea: through needs survey analysis and database status for Chemical Accident Emergency Respond Information System. |
Page:724—735 |
73. Perspectives of clinical epidemiology in Korea. |
Page:718—723 |
74. Opioids use for chronic noncancer pain. |
Page:711—717 |
75. Multiple sclerosis. |
Page:702—708 |
76. Deep brain stimulation: mechanism, surgical procedure, and clinical applications. |
Page:695—701 |
77. Training residents in the prevention of legal disputes. |
Page:686—694 |
78. Recent trend of precedents for National Health Insurance. |
Page:676—685 |
79. Effect of Bioethics and Safety Act in medical research. |
Page:665—675 |
80. Criminal liability of medical professionals. |
Page:655—664 |
81. Civil liability for medical malpractice. |
Page:648—654 |
82. Medical law for physicians. |
Page:646—647 |
83. Concerns about non-anesthesiologists administration of intravenous anesthetics. |
Page:642—644 |
84. The determinants of official development assistance for healthcare in Korea. |
Page:827—836 |
85. Management of sepsis. |
Page:819—826 |
86. Surgical treatment of atrial fibrillation. |
Page:805—816 |
87. Contemporary medical understanding of the 'no-fault accident' during birth: amniotic fluid embolism, pulmonary embolism, meconium aspiration syndrome, and cerebral palsy. |
Page:784—804 |
88. Treating and preventing relapse of drug abuse by healthcare providers. |
Page:778—783 |
89. Propofol abuse among healthcare professionals. |
Page:771—777 |
90. Neurobiology, pharmacokinetics and pharmacodynamics of drug abuse. |
Page:762—770 |
91. Medical environment and drug abuse among physicians: current state and problems in Korea. |
Page:755—761 |
92. Healthcare providers have to be careful with drug abuse in Korea. |
Page:752—754 |
93. Optimal trauma care system in Korea. |
Page:748—750 |
94. Pharmacokinetics and pharmacodynamics of drugs for sedation. |
Page:279—284 |
95. Procedural sedation and analgesia in children. |
Page:271—278 |
96. The current state of sedation outside the operating room. |
Page:264—270 |
97. Procedural sedation. |
Page:262—263 |
98. Medical ethics and self-regulation in Korean medical society. |
Page:258—260 |
99. Clinical chemistry values in elderly Korean people: single institutional study. |
Page:533—540 |
100. Comparative study on medical fees: caesarean section, cataract, and appendectomy surgeries among OECD countries. |
Page:523—532 |
101. Chemotherapeutic drugs for common parasitic diseases in Korea. |
Page:513—522 |
102. Infant and toddler vision care: a supplement to the Manual of Infant Health Screening conducted by Korean National Health Insurance Corporation. |
Page:504—510 |
103. Recent review on blood transfusion therapy. |
Page:496—503 |
104. Measuring stress with questionnaires. |
Page:485—495 |
105. Evidence-based stress management: focusing on nonpharmacological procedure which reduce stress and promote health. |
Page:478—484 |
106. Stress and mental illness. |
Page:471—477 |
107. Stress and cardiovascular disease. |
Page:462—470 |
108. Stress and disease: evidence based review. |
Page:460—461 |
109. Management and perspectives of patient safety in healthcare. |
Page:454—458 |
110. A survey on the appropriate level of premiums for National Health Insurance. |
Page:326—335 |
111. Clinical use of oral contraceptives. |
Page:321—325 |
112. Recent advance on vitamin D. |
Page:310—318 |
113. Presbyopia and contact lenses. |
Page:303—309 |
114. Requirements and circumstances for safe sedation. |
Page:299—302 |
115. Drug abuse associated with procedural sedation. |
Page:292—298 |
116. Issues in procedural sedation outside the operating theater: characteristics and safety of commonly used sedatives and analgesics. |
Page:285—291 |
117. Ethical principles and practice guidelines concerning the usage of public database for medical researches. |
Page:1031—1038 |
118. Antitussive and mucoactive drugs. |
Page:1025—1030 |
119. Prevention and treatment of hallux valgus. |
Page:1017—1022 |
120. Periorbital changes with aging. |
Page:1012—1016 |
121. Management of viral hepatitis in patients with hepatocellular carcinoma. |
Page:1001—1011 |
122. Recent advances in systemic chemotherapy of hepatocellular carcinoma. |
Page:993—1000 |
123. Recent developments in radiotherapy for hepatocellular carcinoma. |
Page:983—992 |
124. Recent advance in international management of hepatocellular carcinoma. |
Page:972—982 |
125. Recent advance of local ablation for hepatocellular carcinoma. |
Page:964—971 |
126. Recent advances in hepatic resection and liver transplantation for hepatocellular carcinoma. |
Page:956—963 |
127. Recent development of diagnostic imaging of hepatocellular carcinoma. |
Page:948—955 |
128. Recent advances in the management of hepatocellular carcinoma. |
Page:946—947 |
129. 1 Years after beginning of DRG services system. |
Page:942—944 |